Black Sun Bio-Weapons – 8 – CanSinoBio COVID-19 Vaccine [CHINA]

COVID-19 VACCINE LETHAL INJECTIONS

GLOBAL GENOCIDE


CanSinoBio
COVID-19 Vaccine

The Official Story

CONVIDECIA COVID-19 VACCINE
(CanSino Biologics, CHINA)


 

AD5-nCOV, trade-named Convidecia, is a single-dose viral vector vaccine for COVID-19 developed by CanSino Biologics. It conducted its Phase III trials in Argentina, Chile, Mexico, Pakistan, Russia, and Saudi Arabia with 40,000 participants.

In February 2021, global data from Phase III trials and 101 COVID cases showed that the vaccine had a 65.7% efficacy in preventing moderate symptoms of COVID-19, and 91% efficacy in preventing severe disease. It has similar efficacy to the Janssen vaccine, another one-shot adenovirus vector vaccine with 66% efficacy in a global trial. Convidecia is similar to other viral vector vaccines like AZD1222, Gam-COVID-Vac, and Ad26.COV2.S. Its single-dose regimen and normal refrigerator storage requirement (2° to 8 °C) could make it a favorable vaccine option for many countries. It is currently under evaluation for emergency use listing by the WHO. On May 19 2022, WHO issued EUL for the vaccine.

A Phase I study published in The Lancet showed two doses of a nasal-spray version of Convidecia resulted in neutralising antibody responses similar to the existing one-dose injection.

Convidecia and the Pakistani version called Pakvac are approved for use by some countries in Asia, Europe, and Latin America. Production capacity for Ad5-NCov should reach 500 million doses in 2021. Manufacturing will take place in China, with filling and finishing of the vaccine additionally also taking place in Malaysia, Mexico, and Pakistan.

Pharmacology

Convidecia is a viral vector vaccine similar to AstraZeneca’s AZD1222 and Gamaleya’s Gam-COVID-Vac.

Authorizations

On 25 June 2020, China approved the vaccine for limited use by the military. In February 2021, China approved the vaccine for general use.

In February 2021, Mexico approved the vaccine for emergency use.

In February 2021, Pakistan approved the vaccine for emergency use.

In March, Hungary approved the vaccine for emergency use.

In March, Moldova authorized use of the vaccine.

On 15 June 2021, Malaysia’s National Pharmaceutical Regulatory Agency (NPRA) has issued conditional registration for emergency use of the vaccine.

On 7 September 2021, National Agency of Drug and Food Control (BPOM) has issued emergency use authorization in Indonesia.

On 4 September 2022, China’s National Medical Products Administration granted approval for the Convidecia Air, an inhaled version of the Convidecia vaccine, to be used as a booster dose.

Source: Wikipedia

BORG/AI ASSIMILATION

(Star Trek: First Contact, 1996)

WAKE UP — WE ARE HERE NOW

Convidecia COVID-19 Vaccine

Convidecia is a viral vector vaccine produced by the Chinese company CanSino Biologics and the Beijing Institute of Biotechnology of the Academy of Military Medical Sciences.

Convidecia Worldwide Authorizations


GLOBAL GENOCIDE 2025 (Click Links Below)

Full (1)

  1. China

Emergency (9)

  1. Argentina
  2. Chile
  3. Ecuador
  4. Indonesia
  5. Malaysia
  6. Mexico
  7. Moldova
  8. Pakistan

Non-country entities

  • World Health Organization

Travel-only

CRIMES AGAINST HUMANITY — NUREMBERG II

The Truth

FALSE FLAG

A false flag is a covert operation designed to deceive; the deception creates the appearance of a particular party, group, or nation being responsible for some activity, disguising the actual source of responsibility.

SUBLIMINAL
adjective

(of a stimulus or mental process) below the threshold of sensation or consciousness; perceived by or affecting someone’s mind without their being aware of it.

YOU KNOW WHAT TIME IT IS…

COVID-19 TRUTH

HISTORICAL TRUTH

HOLOCAUST TRUTH

THE HOLOCAUST
The mass murder of Jews under the German Nazi regime during the period 1941–5. More than 6 million European Jews, as well as members of other persecuted groups, were murdered at concentration camps such as Auschwitz.

THE TIME IS NOW:

AWAKEN HUMANITY

Comments are closed.